Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2006
DOI: 10.1038/sj.onc.1209952
|View full text |Cite
|
Sign up to set email alerts
|

The p53 knowledgebase: an integrated information resource for p53 research

Abstract: The p53 tumor suppressor protein plays a central role in maintaining genomic integrity by occupying a nodal point in the DNA damage control pathway. Here it integrates a wide variety of signals, responding in one of several ways, that is, cell cycle arrest, senescence or programmed cell death (apoptosis). Mutations in the tumor suppressor gene tp53, which affects the key transcriptional regulatory processes in cell growth and death, occur frequently in cancer and helps explain why p53 has been called the guard… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
30
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(30 citation statements)
references
References 24 publications
(20 reference statements)
0
30
0
Order By: Relevance
“…Once activated p53 binds to DNA and transactivates genes encoding proteins responsible for DNA repair, cell cycle arrest, and/or the induction of apoptosis in cells harboring nonrepairable damaged DNA, as well as senescence (42). In this light, it represents a ''guardian'' of genomic integrity preventing the passage of damaged DNA from cell to cell (41).…”
mentioning
confidence: 98%
“…Once activated p53 binds to DNA and transactivates genes encoding proteins responsible for DNA repair, cell cycle arrest, and/or the induction of apoptosis in cells harboring nonrepairable damaged DNA, as well as senescence (42). In this light, it represents a ''guardian'' of genomic integrity preventing the passage of damaged DNA from cell to cell (41).…”
mentioning
confidence: 98%
“…Although these approaches have been useful for identifying potential sequences that may interact with p53, they do not provide for the in vivo assessment of relative transactivation capability from different REs. Sequence differences and strength of binding have been invoked to explain possible differences in transactivation of groups of genes subject to direct control by p53, as for the case of cell-cycle control versus apoptotic genes (ResnickSilverman et al, 1998;Vousden, 2000;Zhao et al, 2000;Kannan et al, 2001;Qian et al, 2002;Lim et al, 2006).…”
mentioning
confidence: 99%
“…Interestingly, this particular nucleotide was first reported to have a C-to-T polymorphism in the TP53 gene in human melanoma tumors, 17 and this SNP is mapped to p53 5 0 UTR of reference p53 nucleotide sequence (GenBank accession number X54156) in p53 knowledge base (http://p53.bii.a-star.edu.sg). 18 The evolutionary distances of the p53 cDNAs (as in table, Supplementary Table 2) were represented as an unrooted dendrogram as generated from ClustalW program (Supplementary Figure 3) that reflects the similarities in the p53 cDNA sequences used for the alignment. 3).…”
Section: Resultsmentioning
confidence: 99%
“…One of these SNPs, C119T, has been reported in human melanoma samples 17 and has been mapped to the 5 0 UTR in p53 knowledge base. 18 Curiously, WT C nucleotide in the 119th position in p53 5 0 UTR has been found to be evolutionarily conserved. Inclusion of SNP2-5 0 UTR in a bicistronic reporter has led to a decrease in the 5 0 UTR IRES activity.…”
Section: Introductionmentioning
confidence: 99%